Shanghai. Rehab robotics exoskeletons. Pivoted to GR-1 general-purpose humanoid 2023 leveraging actuator expertise. Completed its Series E in Jan 2026 (E-series total ~RMB 800M; cumulative funding ~RMB 1.58B), converted to a joint-stock company in Mar 2026 ahead of a possible listing; launched the GR-3 humanoid and has delivered 10,000+ robots cumulatively.